Omega Healthcare Investors Reports Strong Q2 2026 Results
Omega Healthcare Investors, Inc. (NYSE: OHI) has released its financial results for the second quarter ended June 30, 2026, highlighting remarkable growth in net income, Adjusted Funds From Operations (AFFO), and robust investment activity. The results affirm the company's strategic focus on expanding its portfolio and enhancing shareholder value.
1. Second Quarter Highlights
- Net Income Growth: Omega reported a net income of $380 million or $1.19 per diluted share, a significant increase from $140 million or $0.46 per diluted share in Q2 2025.
- Adjusted Funds From Operations (AFFO): AFFO rose to $261 million or $0.83 per diluted share, compared to $232 million or $0.77 per diluted share in the previous year.
- Funds Available for Distribution (FAD): FAD for the quarter was $248 million, translating to $0.78 per diluted share, up from $223 million or $0.74 per diluted share in Q2 2025.
- Net Operating Income (NOI): NOI surged to $331 million, compared to $281 million in the same quarter last year.
Investment Activity
In Q2 2026, Omega completed $126 million in investments, including:
- Real Estate Acquisitions: $110 million was allocated to acquire eight facilities, with expected stabilized yields in the low double digits.
- Real Estate Loan Fundings: $16 million was invested in real estate loans.
Additionally, the company expanded its partnership with Saber Healthcare Holdings, LLC, through a net investment of $124.3 million via the Saber PropCo joint venture, adding 27 facilities to Saber’s operations.
Asset Disposition
The company also completed the strategic sale of 18 CommuniCare facilities, generating gross proceeds of $480 million. This strategic move included a gain of $231.7 million, which bolstered the overall financial position of Omega.
Dividend Increase
Reflecting its strong performance, the Board of Directors declared a quarterly cash dividend of $0.68 per share, an increase of $0.01 per share. This dividend is set to be paid on August 14, 2026, to stockholders of record by August 3, 2026.
2. CEO Insights
CEO Taylor Pickett expressed satisfaction with the company’s performance, noting, “We are pleased to report strong second quarter results, with FAD per share up 6.3% over the same quarter last year. This reflects our continued accretive investment activity, augmented by active portfolio management.” He highlighted a positive outlook for the remainder of the year, driven by a robust pipeline of potential investments.
As he prepares for retirement, Pickett emphasized the favorable operating environment, stating, “Now, as I prepare to retire, I can safely say that this is the most favorable operating backdrop that I have known in my career.”
3. Portfolio Transition and Operator Updates
Ciena Transition
During the second quarter, Omega transitioned 20 skilled nursing facilities (SNFs) previously leased to Ciena Healthcare Management. This strategic move improved the portfolio's credit profile, as the new leases exhibit stronger EBITDAR coverage.
Genesis Healthcare Update
Genesis Healthcare, which filed for Chapter 11 bankruptcy in July 2025, has continued to meet its contractual rent obligations. Omega recognized $13.3 million in rental income from Genesis during the second quarter, alongside $5.9 million in interest income.
4. Financial Outlook
With the recent financial results, Omega has increased its 2026 Adjusted FFO guidance to a range of $3.22 to $3.26 per diluted share. This reflects a strong operational outlook as the company continues to capitalize on growth opportunities while managing risks associated with operator bankruptcies and market fluctuations.
As of June 30, 2026, Omega’s balance sheet remains robust, with $4.1 billion in outstanding indebtedness, a weighted average interest rate of 4.2%, and $2.0 billion in undrawn capacity under its revolving credit facility.
5. Conclusion
The second quarter of 2026 marks a significant achievement for Omega Healthcare Investors, showcasing strong earnings growth, strategic investments, and a commitment to enhancing shareholder returns. As the company navigates through a dynamic healthcare landscape, its proactive management and investment strategies position it well for continued success in the future.
Investors and stakeholders can look forward to more insights during the upcoming conference call scheduled for July 30, 2026, at 10 a.m. ET, where management will discuss the results in further detail.
